(Hypertension. 1997;30:1356-1361.)
© 1997 American Heart Association, Inc.
Articles |
-Adrenergic Signal Transduction in Renin Transgenic Rats
From the Klinik III für Innere Medizin der Universität zu Köln (P.S., T.N., G.N., M.B.) and the Institut für Klinische Pharmakologie der Freien Universität Berlin (M.P.) (Germany).
Abstract The
1-adrenoceptorG
proteinphosphoinositide-specific phospholipase C
(PLC) signal transduction pathway is assumed to play an important role
in the regulation of contractile force and in the pathophysiology of
myocardial hypertrophy. In the present study, the
components of this pathway were investigated in left ventricles of
hearts from hypertensive transgenic rats overexpressing the mouse renin
gene [TG(mREN2)27] in comparison to age- and weight-matched
Sprague-Dawley control rats. Contractile force was assessed in isolated
electrically driven left ventricular papillary muscle
strips.
1-adrenoceptor density was measured by
radioligand binding using [3H]prazosin,
steady state levels of
q/11, and G protein ß-subunits by Western
blotting. PLC activity was determined by a cell-free assay using
exogenous phospholipid vesicles containing
[3H]phosphatidylinositol (4,5)-bisphosphate as a
substrate.
1-Adrenoceptor density was significantly
increased (by 80%) in transgenic rats compared with control rats,
while the positive inotropic response to the
1-adrenoceptor agonist phenylephrine was
significantly reduced, suggesting a postreceptor defect in TG(mREN2)27.
The expression of
q and
11 was verified by reverse
transcriptionpolymerase chain reaction, and
q/11 steady state
protein levels were shown to be similar in transgenic and control rats.
Western blotting using a ß-common antibody revealed two bands at
approximately 35 and 36 kD. The quantities of both were similar in
TG(mREN2)27 compared with those in control rats. In contrast, PLC
activity was significantly reduced (by 32%) in transgenic rats. In
conclusion, our findings are consistent with a desensitization
of the
1-adrenergic signal transduction pathway at the
level of the effector.
Key Words: signal transduction
-adrenoceptors G proteins phospholipase C cardiac hypertrophy
This article has been cited by other articles:
![]() |
L. Cao, M. H. Weil, S. Sun, and W. Tang Vasopressor Agents for Cardiopulmonary Resuscitation Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 115 - 121. [Abstract] [PDF] |
||||
![]() |
S. M. Jacinto, J. J. Mullins, and K. D. Mitchell Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats Am J Physiol Renal Physiol, February 1, 1999; 276(2): F315 - F322. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats Cardiovasc Res, July 1, 1998; 39(1): 242 - 256. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |